Longitudinal cohort studies, which follow individuals over time, are crucial for understanding disease progression, identifying risk factors, and evaluating public health interventions. END-VOC, one of the European Horizon projects funded during the COVID-19 pandemic, brought together 33 cohorts from 24 countries to study the impact of emerging variants on diagnostics, treatments and vaccines. The project contributed